Hospital
Ascension Borgess Allegan Hospital
Ascension Borgess Allegan Hospital was paid $6.03M by Medicaid between Jan 2018 and Dec 2024, across 130 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoASCENSION BORGESS ALLEGAN HOSPITAL
ALLEGAN, MI 49010
ALLEGAN, MI 49010
33aNPI1295803377assigned 11/30/2006
33bProvider typeCritical Access Hospital
28Total paid$6.03M
24GClaims182,229
24DCodes billed130
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Michigan
Rank by total paid#16 of 31
Median peer was paid$6.03M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HOUGHTON, MARINA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,835 | $640K | |
| 2019 | 25,877 | $549K | |
| 2020 | 25,678 | $768K | |
| 2021 | 33,271 | $1.14M | |
| 2022 | 26,496 | $1.05M | |
| 2023 | 29,537 | $1.12M | |
| 2024incomplete | 18,535 | $766K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 8,196 | 7,816 | $1.23M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 5,254 | 4,949 | $1.18M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10% | 6,758 | 6,499 | $630K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.9% | 1,341 | 1,302 | $536K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.4% | 3,133 | 2,944 | $386K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.5% | 4,424 | 4,122 | $330K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.8% | 9,271 | 2,749 | $288K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.3% | 840 | 827 | $201K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.2% | 1,199 | 975 | $132K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.0% | 3,029 | 2,545 | $119K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.9% | 2,914 | 2,589 | $115K |
| 71046 | Radiologic examination, chest; 2 views | 1.8% | 2,343 | 2,301 | $107K |
118 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 2,377 | $84K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 1,566 | $76K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 1,350 | $66K |
| 64493 | <1% | 70 | $47K | |
| 80061 | Lipid panel | <1% | 4,036 | $38K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,057 | $38K |
| 80053 | Comprehensive metabolic panel | <1% | 11,954 | $37K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,293 | $36K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,974 | $28K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,595 | $22K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 141 | $22K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 406 | $20K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,035 | $17K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,447 | $16K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 871 | $16K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 870 | $16K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,945 | $15K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 95 | $14K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 336 | $13K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 206 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,713 | $10K |
| 83655 | <1% | 1,217 | $9K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 494 | $9K |
| 97162 | <1% | 196 | $9K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,121 | $8K |
| 73630 | <1% | 353 | $7K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 45 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,789 | $6K |
| 84439 | <1% | 1,063 | $6K | |
| 97161 | <1% | 121 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,965 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,074 | $5K |
| 72110 | <1% | 67 | $4K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 64 | $4K |
| 81025 | <1% | 2,870 | $3K | |
| 82728 | <1% | 415 | $3K | |
| 73610 | <1% | 160 | $3K | |
| 81002 | <1% | 1,146 | $3K | |
| 82607 | <1% | 261 | $2K | |
| 73130 | <1% | 146 | $2K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 55 | $2K |
| 85610 | <1% | 1,964 | $2K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 47 | $2K |
| 83735 | <1% | 3,608 | $2K | |
| 73030 | <1% | 63 | $2K | |
| 83880 | <1% | 644 | $2K | |
| 73564 | <1% | 27 | $2K | |
| 87186 | <1% | 503 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 98 | $1K |
| 82570 | <1% | 432 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 386 | $1K |
| 82043 | <1% | 339 | $1K | |
| 73110 | <1% | 79 | $1K | |
| 85018 | <1% | 707 | $1K | |
| 88142 | <1% | 82 | $1K | |
| 81001 | <1% | 3,025 | $1K | |
| 73562 | <1% | 45 | $990.55 | |
| 87077 | <1% | 275 | $968.81 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 55 | $896.76 |
| 83690 | <1% | 2,184 | $885.49 | |
| 81003 | <1% | 2,870 | $837.06 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 750 | $705.51 |
| 86140 | <1% | 265 | $649.09 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 60 | $641.11 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 26 | $548.50 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 15 | $374.01 |
| 85652 | <1% | 270 | $370.77 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 65 | $335.14 |
| 87486 | <1% | 64 | $282.56 | |
| 87581 | <1% | 64 | $282.56 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 428 | $232.13 |
| 85027 | <1% | 55 | $190.46 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 12 | $161.18 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 489 | $149.98 |
| 87081 | <1% | 39 | $147.01 | |
| 84484 | <1% | 1,670 | $128.26 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 138 | $94.57 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 109 | $81.64 |
| 86703 | <1% | 12 | $80.20 | |
| 83605 | <1% | 1,204 | $77.17 | |
| 83540 | <1% | 12 | $28.78 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,357 | $24.75 |
| 85730 | <1% | 54 | $18.37 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 461 | $4.84 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,559 | $3.06 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,125 | $2.31 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,599 | $1.99 |
| A9270 | Non-covered item or service | <1% | 7,438 | $1.35 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 261 | $1.30 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,058 | $1.08 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,785 | $0.94 |
| J3490 | Unclassified drugs | <1% | 1,836 | $0.67 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,932 | $0.34 |
| J2704 | Injection, propofol, 10 mg | <1% | 756 | $0.11 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 26 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 150 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 230 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 278 | $0.00 |
| 96376 | 0% | 86 | $0.00 | |
| 64494 | 0% | 69 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 292 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 211 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 125 | $0.00 |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 23 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 13 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 25 | $0.00 |
| 87400 | 0% | 22 | $0.00 | |
| 85380 | 0% | 27 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 155 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 62 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 45 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 149 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 111 | $0.00 |
| 94664 | 0% | 13 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 13 | $0.00 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 13 | $0.00 |
| 64495 | 0% | 13 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOUGHTON, MARINA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Ascension Borgess Hospital | Kalamazoo, MI | $43.08M |
| Ascension Medical Group Promed | Kalamazoo, MI | $10.60M |
| Ascension Medical Group Promed | Portage, MI | $7.97M |
| Ascension Borgess Lee Hospital | Dowagiac, MI | $6.88M |
| Ascension Borgess Hospital | Plainwell, MI | $4.84M |
| Ascension Borgess Allegan Hospital | Allegan, MI | $3.71M |
| Ascension Borgess Hospital | Plainwell, MI | $3.71M |
| Ascension Borgess Lee Hospital | Dowagiac, MI | $2.70M |
| Ascension Medical Group Promed | Kalamazoo, MI | $2.55M |
| Ascension Medical Group Promed | Portage, MI | $2.07M |
| Ascension Medical Group Promed | Portage, MI | $1.64M |
| Ascension Borgess Lee Hospital | Dowagiac, MI | $1.58M |
| Ascension Borgess Hospital | Portage, MI | $1.22M |
| Ascension Borgess Allegan Hospital | Gobles, MI | $298K |
| Ascension Borgess Allegan Hospital | Otsego, MI | $294K |
| Ascension Borgess Allegan Hospital | Fennville, MI | $246K |
| Ascension Borgess Hospital | Kalamazoo, MI | $91K |
| Ascension Borgess Allegan Hospital | Allegan, MI | $55K |
| Ascension Borgess Allegan Hospital | Allegan, MI | $43K |
| Ascension Borgess Hospital | Kalamazoo, MI | $40K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.